BARCELONA, SPAIN — In the large Investigation of the Management of Pericarditis (IMPI) trial of patients with presumed tuberculous pericarditis, neither of two immunotherapies—prednisolone and ...
Since 2000, the proper venues in which to challenge decisions from IMPI included the review recourse proceeding before IMPI itself and/or the nullity trial before the Federal Court for Tax and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results